AI brief of an SEC Form 8-K · Aimei Health Technology Co., Ltd. (AFJK)

Aimei Health extends SPAC deadline to Oct. 6, 2026 with $34,330.96 unsecured note

Neutral Impact 3 of 5 financing Written later

Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend its deadline to complete a business combination from September 6, 2026 to October 6, 2026, and issued an unsecured, non-interest-bearing promissory note to fund the payment. The note is due only upon closing of the planned business combination with United Hydrogen, and the payee may convert it into private units at $10.00 each.

Key points

  • Extension payment of $34,330.96, the lesser of $80,000 total or $0.033 per public share
  • Termination date moves from September 6, 2026 to October 6, 2026; this is the 22nd extension permitted
  • Promissory note issued September 3, 2026 to Aimei Investment Ltd, with no interest and principal due at the business combination with United Hydrogen
  • Payee may convert the note into private units at $10.00 per unit, each with one ordinary share and one right to one-fifth of a share

The filing

CompanyAimei Health Technology Co., Ltd. (AFJK)
Form8-K, current report
Filed with the SECSep 3, 2026, 8:00 AM ET
Accession number0001493152-26-041316

Items reported: 2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.